Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-11-007942
Filing Date
2011-02-11
Accepted
2011-02-10 17:57:46
Documents
1
Effectiveness Date
2011-02-11
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9053
  Complete submission text file 0001140361-11-007942.txt   10515
Mailing Address 555 WEST 12TH AVENUE, SUITE 600 VANCOUVER A1 V5Z3X7
Business Address 555 WEST 12TH AVENUE, SUITE 600 VANCOUVER A1 V5Z3X7 604-629-9223
AQUINOX PHARMACEUTICALS (USA) INC (Filer) CIK: 0001404644 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-155188 | Film No.: 11594024